Frequently Asked Questions
The Live Attenuated Vaccines Market size will be worth USD 42,145.42 million during the forecast period.
The Live Attenuated Vaccines Market growth rate is 12.3% during the forecast period.
The Growing Emphasis on Preventive Healthcare, Expanding Vaccination Programs and Prevalence of Infectious Diseases are the growth drivers of the Live Attenuated Vaccines Market.
The product type, development, indication, mode of administration, distribution channel, and end user are the factors on which the Live Attenuated Vaccines Market research is based.
The major companies in the Live Attenuated Vaccines Market are GlaxoSmithKline, plc. (U.K.), Merck & Co. (U.S.), Pfizer, Inc. (U.S.), Astellas Pharma Inc. (Japan), Johnson & Johnson (U.S.), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), MedImmune, LLC (U.S.), Sanofi (France), Serum Institute of India Pvt. Ltd. (India).
